Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naomi V Dahl

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Nephrology News & Issues|September 29, 2005
Q & A: ask the expertsNaomi V Dahl
Seminars in Dialysis|March 5, 2002
Herbs, menopause, and dialysisBeatrix Roemheld-Hamm, Naomi V Dahl
Seminars in Dialysis|April 10, 2008
Thrombosis with erythropoietic stimulating agents-does iron-deficient erythropoiesis play a role?Naomi V Dahl, David H Henry, Daniel W Coyne
American Journal of Hematology|January 21, 2012
Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV ironDavid H Henry, Naomi V Dahl, Michael A Auerbach
Urologic Nursing|March 12, 2013
Application drying time for oxybutynin chloride topical gelDiane K Newman, Scott M Olsen, Naomi V Dahl
Clinical Journal of the American Society of Nephrology : CJASN|October 19, 2007
Single-dosage pharmacokinetics of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patientsBradley A Warady, Paul A Seligman, Naomi V Dahl
Clinical Journal of the American Society of Nephrology : CJASN|September 30, 2010
Proteinuria induced by parenteral iron in chronic kidney disease--a comparative randomized controlled trialRajiv Agarwal, David J Leehey, Scott M Olsen, et al.
BMC Hematology|July 28, 2016
Ferumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemiaWilliam E Strauss, Naomi V Dahl, Zhu Li, et al.
Clinical Drug Investigation|August 23, 2012
Cognitive effects of oxybutynin chloride topical gel in older healthy subjects: a 1-week, randomized, double-blind, placebo- and active-controlled studyGary G Kay, David R Staskin, Scott MacDiarmid, et al.
Journal of Blood Medicine|December 22, 2017
Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancerSaroj Vadhan-Raj, Naomi V Dahl, Kristine Bernard, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Nephrology News & Issues|September 29, 2005
Q & A: ask the expertsNaomi V Dahl
Seminars in Dialysis|March 5, 2002
Herbs, menopause, and dialysisBeatrix Roemheld-Hamm, Naomi V Dahl
Seminars in Dialysis|April 10, 2008
Thrombosis with erythropoietic stimulating agents-does iron-deficient erythropoiesis play a role?Naomi V Dahl, David H Henry, Daniel W Coyne
American Journal of Hematology|January 21, 2012
Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV ironDavid H Henry, Naomi V Dahl, Michael A Auerbach
Urologic Nursing|March 12, 2013
Application drying time for oxybutynin chloride topical gelDiane K Newman, Scott M Olsen, Naomi V Dahl
Clinical Journal of the American Society of Nephrology : CJASN|October 19, 2007
Single-dosage pharmacokinetics of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patientsBradley A Warady, Paul A Seligman, Naomi V Dahl
Clinical Journal of the American Society of Nephrology : CJASN|September 30, 2010
Proteinuria induced by parenteral iron in chronic kidney disease--a comparative randomized controlled trialRajiv Agarwal, David J Leehey, Scott M Olsen, et al.
BMC Hematology|July 28, 2016
Ferumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemiaWilliam E Strauss, Naomi V Dahl, Zhu Li, et al.
Clinical Drug Investigation|August 23, 2012
Cognitive effects of oxybutynin chloride topical gel in older healthy subjects: a 1-week, randomized, double-blind, placebo- and active-controlled studyGary G Kay, David R Staskin, Scott MacDiarmid, et al.
Journal of Blood Medicine|December 22, 2017
Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancerSaroj Vadhan-Raj, Naomi V Dahl, Kristine Bernard, et al.
Pageof 3